Skip to content
Home/Companies/MedTech/Cellnovo

Cellnovo

MedTech·France·Exited 2015·Held 4yr
Entry
2011
Hold
4yr
Exit
2015

Who owns Cellnovo?

Cellnovo is a French MedTech company, formerly owned by Andera Partners, exited in 2015 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 3 · 2009 · VC

Key facts

HQFrance
SectorMedTech
Exit Type
IPO
Exit Year
2015

More from BioDiscovery 3

Other portfolio companies in the same fund.

GenKyoTex
Exited 2014
BiotechFrance· 2011
Sapiens
Sapiens
Exited 2013
SaaSFrance· 2011
to Medtronic
Covagen
Exited 2014
BiotechFrance· 2010
to Johnson & Johnson
Parvulus Medical
Exited
MedTechFrance· 2010
Poxel
Poxel
Active
BiotechFrance· 2010
Endosense
Exited 2013
MedTechFrance· 2009
to St. Jude Medical

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Cellnovo?

Cellnovo was formerly owned by Andera Partners, exited in 2015. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue